CHRS
Coherus Oncology
--
--(--)
Market Open: --
--
--(--)
Post-Market: --
CHRS Profile
Coherus Oncology, Inc.
A commercial stage biopharmaceutical company that builds a leading immuno-oncology franchise
333 Twin Dolphin Drive, Suite 600, Redwood City, California 94065
--
Coherus Oncology, Inc., was incorporated in Delaware in September 2010. The Company is a commercial-stage biopharmaceutical company focused on the research, development and commercialization of innovative cancer treatments and the commercialization of approved biosimilar combinations. The company's strategy is to build a leading immuno-oncology franchise, funded by cash generated through net sales of a diverse portfolio of U.S. Food and Drug Administration-approved therapies.